8.56

3.38% 0.28

Treace Medical Concepts Inc (TMCI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$8.28

Offen:

$8.36

24-Stunden-Volumen:

261.27K

Relative Volume:

0.46

Marktkapitalisierung:

$527.03M

Einnahmen:

$198.53M

Nettoeinkommen (Verlust:

$-63.68M

KGV:

-11.73

EPS:

-0.73

Netto-Cashflow:

$-41.50M

1W Leistung:

+7.27%

1M Leistung:

+82.52%

6M Leistung:

+65.89%

1J Leistung:

-3.06%

1-Tages-Spanne:

$8.36

$8.60

1-Wochen-Bereich:

$7.735

$8.75

52-Wochen-Spanne:

$3.92

$15.98

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Firmenname

Treace Medical Concepts Inc

Sektor

Healthcare (1200)

Branche

Medical Devices (153)

Telefon

(904) 373-5940

Adresse

100 PALMETTO PARK PLACE, PONTE VEDRA

Mitarbeiter

227

Twitter

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

TMCI's Discussions on Twitter

Vergleichen Sie TMCI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TMCI Treace Medical Concepts Inc	8.56	527.03M	198.53M	-63.68M	-41.50M	-0.73
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-05-16	Herabstufung	UBS	Buy → Neutral
2024-05-08	Herabstufung	BTIG Research	Buy → Neutral
2024-05-08	Herabstufung	JP Morgan	Overweight → Neutral
2024-05-08	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-05-08	Herabstufung	Stifel	Buy → Hold
2024-05-08	Herabstufung	Truist	Buy → Hold
2023-09-29	Eingeleitet	UBS	Buy
2023-05-01	Eingeleitet	Truist	Buy
2023-04-11	Eingeleitet	Stephens	Equal-Weight
2022-05-12	Eingeleitet	BTIG Research	Buy
2022-01-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-05-18	Eingeleitet	JP Morgan	Overweight
2021-05-18	Eingeleitet	Morgan Stanley	Equal-Weight
2021-05-18	Eingeleitet	SVB Leerink	Outperform
2021-05-18	Eingeleitet	Stifel	Buy

Alle ansehen

Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten

Nov 27, 2024

Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World

Nov 27, 2024

Nov 26, 2024

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus.com

Nov 26, 2024

Nov 24, 2024

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Nov 24, 2024

Nov 18, 2024

Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times

Nov 18, 2024

Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024

Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com

Nov 14, 2024

Nov 09, 2024

Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks

Nov 09, 2024

Morgan Stanley's Strategic Reduction in Treace Medical Concepts Inc. - GuruFocus.com

Nov 09, 2024

Nov 07, 2024

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Nov 06, 2024

Earnings call: Treace Medical Concepts reported an 11% increase in third-quarter revenue - Investing.com India

Nov 06, 2024

U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn

Nov 06, 2024

Treace Medical (TMCI) Experiences Stock Boost After Reporting Strong Results - Stocks Telegraph

Nov 06, 2024